Wallace Capital Management’s Immunomedics Inc IMMU Stock Holding History

Wallace Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,573	Closed	-$814K	–	68
2020 Q3	$814K	Sell	9,573 -9,571	-50%	-$484K	0.14%	47
2020 Q2	$678K	Sell	19,144 -6,356	-25%	-$186K	0.12%	45
2020 Q1	$344K	Hold	25,500	–	–	0.07%	48
2019 Q4	$540K	Hold	25,500	–	–	0.07%	43
2019 Q3	$338K	Hold	25,500	–	–	0.04%	52
2019 Q2	$354K	Hold	25,500	–	–	0.05%	54
2019 Q1	$490K	Hold	25,500	–	–	0.07%	46
2018 Q4	$364K	Hold	25,500	–	–	0.05%	51
2018 Q3	$531K	Hold	25,500	–	–	0.07%	52
2018 Q2	$604K	Hold	25,500	–	–	0.08%	52
2018 Q1	$373K	Buy	+25,500	New	+$417K	0.05%	59

Wallace Capital Management's IMMU Position: Q4 2020 in Review

Wallace Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 9,573 shares — an estimated $814K sold.

Wallace Capital Management first reported a position in IMMU in Q1 2018 and held it in 11 quarters. The position peaked at $814K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Wallace Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Wallace Capital Management sold 9,573 Immunomedics Inc shares in Q4 2020, an estimated $814K.
Wallace Capital Management first reported a position in Immunomedics Inc in Q1 2018 and held it in 11 quarters.
Wallace Capital Management's Immunomedics Inc position peaked at $814K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Wallace Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.